Sudarshan Chemical Industries (506655) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
1 Oct, 2026Executive summary
Completed acquisition and integration of Heubach and Clariant pigment businesses, creating a top-2 global pigment leader with 19 manufacturing sites across 11 countries and a broad product portfolio.
Q1 FY26 marked the first full quarter post-acquisition, with consolidated sales of ₹2,507 crore and adjusted EBITDA of ₹165 crore.
Integration efforts focused on harmonizing processes, launching unified GTM strategies, and stabilizing operations, with improved product availability and customer centricity.
Recognized for sustainability and ESG excellence, including EcoVadis Gold rating, Mahatma Award 2024, and supplier awards from coatings and plastics industries.
Major board changes included appointment of Rajesh Rathi as Chairman and Managing Director and new independent directors.
Financial highlights
Q1 FY26 consolidated revenue: ₹2,507 crore, up from ₹633.6 crore in Q1 FY25, reflecting the Heubach acquisition.
Adjusted EBITDA: ₹165 crore (margin 6.6–6.7%), up from ₹81 crore YoY; EBITDA for Q1 FY26 stood at ₹192.4 crore.
Pigment segment Q1 revenue: ₹2,456 crore; EBITDA: ₹192.2 crore.
Net debt at quarter end: ₹1,084 crore, up from previous quarter due to acquisition payments.
Exceptional items included integration/restructuring costs of ₹32.8 crore and a bargain purchase gain of ₹1,243.9 crore.
Outlook and guidance
Q1 and Q2 expected to be flat or slightly down, with sales ramp-up anticipated by year-end and improved demand in coming quarters.
Acquired group targets EBITDA of €35 million in FY26 and €90–100 million by FY28/29.
Legacy Sudarshan business aims for 8–10% revenue growth by year-end, despite a soft Q2.
Working capital targeted to reduce from 24–25% to 21% of revenue.
Purchase Price Allocation for the acquisition is provisional and will be finalized within one year.
Latest events from Sudarshan Chemical Industries
- Q1 FY25 saw higher revenue, EBITDA, and margins, with normalized profit and improved leverage.506655
Q1 24/25 - Heubach acquisition adds global scale, with full benefits targeted within two years.506655
M&A announcement - Record pigment sales lifted margins as Heubach acquisition advanced.506655
Q2 24/25 - Q3 FY25 saw strong revenue growth, margin gains, and progress on the Heubach acquisition despite costs.506655
Q3 24/25 - Heubach lifts FY25 sales and adjusted EBITDA, with profitability targets hinging on integration.506655
Q4 24/25 - Q2 sales grew despite destocking; Heubach guidance fell as integration advanced.506655
Q2 25/26 - Weak demand drove a consolidated loss, while cost savings and restocking signal recovery.506655
Q3 25/26 - Q4 growth, acquired-group recovery and debt reduction support FY27 plans amid cost risks.506655
Q4 25/26 - Q1 FY27 saw robust revenue, EBITDA, and profit growth, with improved capital efficiency and restructuring.506655
Q1 26/27